• SENSEX 81,463.09
    -721.08 (--0.88%)
  • BANKNIFTY 56,528.90
    -537.15 (--0.94%)
  • Authum Invest
    2,250.00 985.45(%)
  • Indian Energy Ex
    149.45 244.35(%)
  • Vimta Labs
    598.90 598.90(%)
  • Bharti Airtel
    1,952.40 2,045.50(%)
  • Force Motors
    16,488.00 6,128.55(%)
  • Bajaj Finance
    897.65 642.61(%)
  • Anant Raj
    606.00 947.25(%)
  • Jayaswal Neco
    40.05 26.06(%)
  • Sharda Cropchem
    1,090.25 1,090.25(%)
  • Infosys
    1,511.35 1,307.10(%)
  • Olectra Greentec
    1,460.00 973.65(%)
  • Tata Motors
    685.00 542.55(%)
  • Eternal Ltd
    306.25 189.60(%)
  • Trent
    5,033.80 4,491.75(%)
  • Reliance Industr
    1,384.50 1,115.55(%)
  • Waaree Energies
    3,171.00 1,808.65(%)
  • Phoenix Mills
    1,545.00 1,965.00(%)
  • Kajaria Ceramics
    1,151.00 745.00(%)
  • Adani Green
    972.75 758.00(%)
  • Cipla
    1,553.00 1,702.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Neuland Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 3800.0
  • ISIN : INE794A01010
13,760.00 -41 (-0.30%)
  • As on 26 Jul 2025 (EOD)

  • Today’s Low

    13,626.00

  • Today’s High

    14,045.00

  • Open

    13,811.00

  • Perv Close

    13,801.00

  • 52W Low

    8,270.00

  • 52W High

    18,100.00

Key Indicators

  • P/E(TTM)

    84.93

  • Mar.Cap (₹Cr.)

    17,653.93

  • Div & Yield %

    0.09

  • Book Value(₹)

    1,182.30

  • Debt-Equity Ratio

    -0.30

  • AGM Date

    25-Jul-2025

  • EPS

    161.75

  • P/E Ratio

    84.93

Financials Ratios

  • Debt-Equity Ratio

    0.10

  • Mar.Cap (₹Cr.)

    17,653.93

  • RONW (%)

    26.38

  • ROCE (%)

    33.01

Score Board

  • Equity (₹ in Cr.)

    12.83

  • BV (₹)

    1,182.30

  • Sales( ₹ in Cr.)

    1,476.84

  • NP (in Cr.)

    207.53

  • NP Var(%)

    -31.0

  • Div%

    120.0

  • CPS (₹)

    212.80

  • EPS (₹)

    161.80

  • Traded Value (₹ in Lakhs)

    17,623.97

  • 52 Week High

    18,100.00

  • 52 Week Low

    8,270.00

  • Price BSE

    13737.0

  • Price NSE

    13,760.00

  • Market Capital( in Cr.)

    17,623.97

  • P/C Ratio

    64.50

  • P/E Ratio

    84.90

  • Price Vs.BV

    161.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 1,476.84 1,558.58 1,191.20 951.08 936.91 762.71
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,476.84 1,558.58 1,191.20 951.08 936.91 762.71
Other Income 96.91 12.54 9.75 2.08 16.09 3.89
Stock Adjustments -12.83 55.14 9.51 15.41 1.24 11.16
Total Income 1,560.92 1,626.26 1,210.46 968.57 954.24 777.76
EXPENDITURE :            
Raw Materials 578.45 636.49 491.98 441.79 443.04 394.41
Power and Fuel Cost 50.56 48.72 48.62 42.21 39.21 32.75
Employee Cost 261.40 248.53 194.84 175.76 144.02 118.48
Other Manufacturing Expenses 108.66 103.73 82.69 84.92 73.71 61.79
Selling and Administration Expenses 120.52 104.29 88.50 70.50 79.80 51.76
Miscellaneous Expenses 22.11 10.04 22.77 9.12 11.93 13.21
Employee Benefit Expenses 261.40 248.53 194.84 175.76 144.02 118.48
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,141.71 1,151.81 929.40 824.29 791.71 672.41
Operating Profit 419.22 474.47 281.06 144.27 162.54 105.34
Interest 8.30 14.00 13.07 13.49 17.90 21.57
Gross Profit 410.92 460.47 267.99 130.78 144.64 83.77
Depreciation 65.54 59.70 52.78 49.04 39.68 31.28
Profit Before Tax 345.38 400.77 215.21 81.74 104.96 52.49
Current Tax 73.65 99.59 50.39 20.42 12.48 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 12.29 1.59 1.70 -2.22 12.18 36.62
Reported Net Profit 259.43 299.60 163.12 63.53 80.29 15.88
Extraordinary Items 51.90 -0.30 -0.66 -1.36 9.81 0.12
Adjusted Net Profit 207.53 299.90 163.78 64.89 70.48 15.76
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 -0.18
P & L Balance brought forward 747.31 460.54 303.84 244.15 166.42 155.67
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 17.96 12.83 6.41 3.85 2.57 4.95
P & L Balance carried down 988.77 747.31 460.54 303.84 244.15 166.42
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 120.00 140.00 100.00 50.00 50.00 20.00
Dividend Per Share(Rs) 12.00 14.00 10.00 5.00 5.00 2.00
Earnings Per Share-Unit Curr 201.10 232.24 126.44 49.25 62.24 12.31
Earnings Per Share(Adj)-Unit Curr 201.10 232.24 126.44 49.25 62.24 12.31
Book Value 1,175.89 988.88 765.49 647.06 605.44 546.26
Book Value(Adj)-Unit Curr 1,175.89 988.88 765.49 647.06 605.44 546.26

Shareholding Pattern

  • Promoter Group

    32.68%

  • Public Share Holding

    67.32%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 200 200.00 200 200
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 200 0.00 200 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 858,632 6.69 858,632 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 3,333,352 25.98 3,333,352 1
Others 0 0.00 0 0
Sub Total 4,191,984 32.67 4,191,984 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 51,304 0.40 51,304 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 2,782,819 21.69 2,782,819 188
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 179,081 1.40 179,081 6
Mutual Funds / UTI 982,647 7.66 982,647 25
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 322,430 2.51 322,430 39
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 4,318,281 33.66 4,318,281 259
2] Non Institution
Bodies Corporate 719,499 5.61 718,699 693
Clearing Members 6,318 0.05 6,318 5
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 161,092 1.26 148,592 1,124
Foreign Non Institution Other 100 0.00 0 1
Hindu Undivided Families 87,494 0.68 86,094 874
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 881,445 6.87 881,445 9
Individuals holding nominal share capital up to Rs. 1 lakh 2,396,251 18.68 2,348,032 39,428
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 22,367 0.17 22,367 13
Others 44,858 0.35 44,858 1
Sub Total 4,319,424 33.67 4,256,405 42,148
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 12,829,889 100.00 12,766,870 42,419

Company Background

Neuland Laboratories LtdPharmaceuticals - Indian - Bulk Drugs

  • Neuland Laboratories Ltd
  • BSE Code : 3800.0
  • ISIN : INE794A01010

  • Incorporation Year

    1984

  • Registered Office

    11 Th Floor Phoenix IVY Buildi
    Plot No 573A-III Road No 82, Hyderabad,
    Telangana-500035

  • Telephone

    91-40-30211600

  • FAX

    91-40-30211602

  • Chairman

    D Saharsh Rao

  • Managing Director

    D Saharsh Rao

  • Company Secretary

    Sarada Bhamidipati

  • Auditor

    MSKA & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Neuland Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Neuland Labs. 13,736.65 1,497.35 1,476.84 67.94 18.61
Abbott India 33,771.20 6,684.73 6,409.15 50.74 44.95
Astrazeneca Phar 8,832.65 1,756.92 1,716.29 190.77 32.94
P & G Health Ltd 5,831.90 1,166.89 1,151.26 38.54 39.76
Glaxosmi. Pharma 3,154.75 3,866.05 3,723.49 58.15 58.72
Cipla 1,531.10 20,029.57 19,044.85 23.98 21.40
Amrutanjan Healt 679.00 437.58 421.23 38.62 20.84
Fermenta Biotec. 375.35 442.21 430.53 16.34 17.61
Guj. Themis Bio. 363.35 174.19 169.82 81.10 44.82
Bliss GVS Pharma 153.45 703.42 667.20 23.46 9.16
Ambalal Sarabhai 32.88 19.33 4.04 30.44 2.10